Javaid, M. Kassim http://orcid.org/0000-0001-7985-0048
Calo, M.
Wullich, S.
Mohsin, Z.
Osorio, E. Castro
Orjuela, A. Medina
Unigarro, C. Arteaga
Mendez-Sanchez, L.
Naranjo, J. Torres
Vieira, L. Tikle
Tutiya, K. Kuraoka
Inacio, A. Manoel
de Leon, A. Olascoaga-Gomez
García, J. Carlos Viveros
Habib, C.
Subies, F.
Guyot, J. P.
Diehl, M.
Carabelli, G.
Soulie, A.
Cooper, C.
Funding for this research was provided by:
Amgen/ UCB
Article History
Received: 29 June 2022
Accepted: 3 April 2023
First Online: 7 July 2023
Declarations
:
: M. Kassim Javaid has received honoraria and institutional grant support from Amgen Ltd, UCB, Besin Healthcare, Sanofi, Kyowa Kirin.M. Calo declares no conflict of interest.S. Wullich declares no conflict of interest.Z. Mohsin declares no conflict of interest.E. Castro Osorio declares no conflict of interest.A. Medina declares no conflict of interest for this article, but has been speaker for Amgen, Eli Lilly and FAES Farma.C. Arteaga Unigarro declares no conflict of interest for this article, but has been speaker for Amgen.L. Mendez-Sanchez declares no conflict of interest.J. Torres Naranjo declares no conflict of interest for the context of this paper, but received several ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Carnot, Eli Lilly, GSK, Sanofi-Aventis.L. Tikle Vieira declares no conflict of interest.K. Kuraoka Tutiya declares no conflict of interest.A. Manoel Inacio declares no conflict of interest.A. Olascoaga-Gomez de Leon has received honoraria from Amgen Ltd but declares no conflict of interest related to the context of this paper.J. Carlos Viveros García declares no conflict of interest for this article, but has received honoraria from Amgen Ltd.C. Habib declares no conflict of interest.F. Subies declares no conflict of interest.J.P. Guyot declares no conflict of interest.M. Diehl declares no conflict of interest regarding this paper. PI of a research project that receives funding from AMGEN.G. Carabelli declares no conflict of interest.A. Soulie declared that she has no conflict of interest.C. Cooper has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work.Disclaimer. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.